Neurophysiological investigations of hepatic encephalopathy: ISHEN practice guidelines

Liver International

Volumn 29, Issue 6, 2009, Pages 789-796

  Guerit, Jean Michel ^a   Amantini, Aldo ^b   Fischer, Catherine ^c   Kaplan, Peter W ^d   Mecarelli, Oriano ^e   Schnitzler, Alfons ^f   Ubiali, Emilio ^g   Amodio, Piero ^h  

^a Institut Medical Edith Cavell   (Belgium)

^b University Hospital   (Italy)

^c HÔPITAL NEUROLOGIQUE   (France)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e SAPIENZA UNIVERSITY OF ROME   (Italy)

^f HEINRICH HEINE UNIVERSITY   (Germany)

^g Bergamo Hospital   (Italy)

^h UNIVERSITY OF PADOVA   (Italy)

Author keywords

Acute liver failure; Cirrhosis; Electro encephalogram; Encephalopathy; Evoked potentials; Neurophysiology

Indexed keywords

BENZODIAZEPINE; FLUMAZENIL;

BRAIN EDEMA; BRAIN FUNCTION; COGNITION; DISEASE SEVERITY; DRUG DOSE INCREASE; ELECTROENCEPHALOGRAPHY; EVOKED BRAIN STEM AUDITORY RESPONSE; EVOKED MUSCLE RESPONSE; EVOKED RESPONSE; EVOKED SOMATOSENSORY RESPONSE; EVOKED VISUAL RESPONSE; HEPATIC ENCEPHALOPATHY; HUMAN; INTRACRANIAL PRESSURE; LIVER FAILURE; LIVER TRANSPLANTATION; NEUROLOGIC EXAMINATION; NEUROPHYSIOLOGY; PRACTICE GUIDELINE; REVIEW; SEIZURE; SENSORY STIMULATION;

BRAIN STEM; ELECTROENCEPHALOGRAPHY; EVOKED POTENTIALS; HEPATIC ENCEPHALOPATHY; HUMANS; NEUROPHYSIOLOGY; SOCIETIES, SCIENTIFIC;

EID: 65949091074     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2009.02030.x     Document Type: Review

References (56)

1. Niedermeyer E. Metabolic central nervous system disorders. In: Niedermeyer E, Lopes Da Silva F, eds. Electroencephalography. Basic Principles, Clinical Applications, and Related Fields. Baltimore: Williams & Wilkins, 1993; 405-18.
2. Deuschl G, Eisen A. Recommendations for the practice of clinical neurophysiology: Guidelines of the International Federation of Clinical Neurophysiology (2nd Revised and Enlarged Edition). Electroencephalogr Clin Neurophysiol 1999; 52(Suppl.): 3-304.
3. European Association for the Study of the Liver. EASL Clinical Practice Guidelines: Management of Chronic hepatitis B. J Hepatol 2009; 50: 227-42.
4. Guérit JM, Fischer C, Facco E, et al. Standards of clinical practice of EEG and EPs in comatose and other unresponsive states. The International Federation of Clinical Neurophysiology 3. Electroencephalogr Clin Neurophysiol 1999; 52(Suppl.): 117-31.
5. Guerit JM, De Tourtchaninoff M, Soveges L, Mahieu P. The prognostic value of three-modality evoked potentials (TMEPs) in anoxic and traumatic comas. Neurophysiol Clin 1993; 23: 209-26.
6. Guerit JM. Medical technology assessment EEG and evoked potentials in the intensive care unit. Neurophysiol Clin 1999; 29: 301-17.
7. Ikeda A, Klem GH, Lüders HO. Metabolic, infectious, and hereditary encephalopathies. In: Ebersole J, Pedley TA, eds. Current Practice of Clinical Electroencephalography. Philadelphia, USA: Lippincot William & Wilkins, 2003; 348-77.
8. Blume WT. Drug effects on EEG. J Clin Neurophysiol 2006; 23: 306-11.
9. Kaplan PW. The EEG in metabolic encephalopathy and coma. J Clin Neurophysiol 2004; 21: 307-18.
10. Kullmann F, Hollerbach S, Lock G, et al. Brain electrical activity mapping of EEG for the diagnosis of (sub)clinical hepatic encephalopathy in chronic liver disease. Eur J Gastroenterol Hepatol 2001; 13: 513-22.
11. Montagnese S, Jackson C, Morgan MY. Spatio-temporal decomposition of the electroencephalogram in patients with cirrhosis. J Hepatol 2007; 46: 447-58.
12. Sagales T, Gimeno V, De LC, et al. Brain mapping analysis in patients with hepatic encephalopathy. Brain Topogr 1990; 2: 221-8.
13. Barbaro G, Di Lorenzo G, Soldini M, et al. Flumazenil for hepatic encephalopathy grade III and IVa in patients with cirrhosis: An Italian multicenter double-blind, placebo-controlled, cross-over study. Hepatology 1998; 28: 374-8.
14. Amodio P, Marchetti P, Del Piccolo F, et al. Spectral versus visual EEG analysis in mild hepatic encephalopathy. Clin Neurophysiol 1999; 110: 1334-44.
15. Amodio P, Pellegrini A, Ubiali E, et al. The EEG assessment of low-grade hepatic encephalopathy: Comparison of an artificial neural network-expert system (ANNES) based evaluation with visual EEG readings and EEG spectral analysis. Clin Neurophysiol 2006; 117: 2243-51.
16. Amodio P, Del Piccolo F, Petteno E, et al. Prevalence and prognostic value of quantified electroencephalogram (EEG) alterations in cirrhotic patients. J Hepatol 2001; 35: 37-45.
17. Guérit JM. Les potentiales Évoqués, 2nd edn. Paris: Masson, 1993.
18. Kono I, Ueda Y, Nakajima K, et al. Subcortical impairment in subclinical hepatic encephalopathy. J Neurol Sci 1994; 126: 162-7.
19. Mehndiratta MM, Sood GK, Sarin SK, Gupta M. Comparative evaluation of visual, somatosensory, and auditory evoked potentials in the detection of subclinical hepatic encephalopathy in patients with nonalcoholic cirrhosis. Am J Gastroenterol 1990; 85: 799-803.
20. Nolano M, Guardascione MA, Amitrano L, et al. Cortico-spinal pathways and inhibitory mechanisms in hepatic encephalopathy. Electroencephalogr Clin Neurophysiol 1997; 105: 72-8.
21. Oria M, Raguer N, Chatauret N, et al. Functional abnormalities of the motor tract in the rat after portocaval anastomosis and after carbon tetrachloride induction of cirrhosis. Metab Brain Dis 2006; 21: 297-308.
22. Romero-Gomez M, Boza F, Garcia-Valdecasas MS, Garcia E, Aguilar-Reina J. Subclinical hepatic encephalopathy predicts the development of overt hepatic encephalopathy. Am J Gastroenterol 2001; 96: 2718-23.
23. Utku U, Asil T, Balci K, Uzunca I, Celik Y. Hepatic myelopathy with spastic paraparesis. Clin Neurol Neurosurg 2005; 107: 514-6.
24. Amodio P, Quero JC, Del Piccolo F, Gatta A, Schalm SW. Diagnostic tools for the detection of subclinical hepatic encephalopathy: Comparison of standard and computerized psychometric tests with spectral-EEG. Metab Brain Dis 1996; 11: 315-27.
25. Hartmann IJ, Groeneweg M, Quero JC, et al. The prognostic significance of subclinical hepatic encephalopathy. Am J Gastroenterol 2000; 95: 2029-34.
26. Quero JC, Hartmann IJ, Meulstee J, Hop WC, Schalm SW. The diagnosis of subclinical hepatic encephalopathy in patients with cirrhosis using neuropsychological tests and automated electroencephalogram analysis. Hepatology 1996; 24: 556-60.
27. Van Der Rijt CC, Schalm SW, De Groot GH, De Vlieger M. Objective measurement of hepatic encephalopathy by means of automated EEG analysis. Electroencephalogr Clin Neurophysiol 1984; 57: 423-6.
28. Douglass A, Al Mardini H, Record C. Amino acid challenge in patients with cirrhosis: A model for the assessment of treatments for hepatic encephalopathy. J Hepatol 2001; 34: 658-64.
29. Saxena N, Bhatia M, Joshi YK, Garg PK, Tandon RK. Auditory P300 event-related potentials and number connection test for evaluation of subclinical hepatic encephalopathy in patients with cirrhosis of the liver: A follow-up study. J Gastroenterol Hepatol 2001; 16: 322-7.
30. Saxena N, Bhatia M, Joshi YK, et al. Electrophysiological and neuropsychological tests for the diagnosis of subclinical hepatic encephalopathy and prediction of overt encephalopathy. Liver 2002; 22: 190-7.
31. Amodio P, Valenti P, Del Piccolo F, et al. P300 latency for the diagnosis of minimal hepatic encephalopathy: Evidence that spectral EEG analysis and psychometric tests are enough. Dig Liver Dis 2005; 37: 861-8.
32. Kramer L, Bauer E, Gendo A, et al. Neurophysiological evidence of cognitive impairment in patients without hepatic encephalopathy after transjugular intrahepatic portosystemic shunts. Am J Gastroenterol 2002; 97: 162-6.
33. Schiff S, Vallesi A, Mapelli D, et al. Impairment of response inhibition precedes motor alteration in the early stage of liver cirrhosis: A behavioral and electrophysiological study. Metab Brain Dis 2005; 20: 381-92.
34. Schiff S, Mapelli D, Vallesi A, et al. Top-down and bottom-up processes in the extrastriate cortex of cirrhotic patients: An ERP study. Clin Neurophysiol 2006; 117: 1728-36.
35. Conn HO, Leevy CM, Vlahcevic ZR, et al. Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. A double blind controlled trial. Gastroenterology 1977; 72: 573-83.
36. Madl C, Grimm G, Ferenci P, et al. Serial recording of sensory evoked potentials: A noninvasive prognostic indicator in fulminant liver failure. Hepatology 1994; 20: 1487-94.
37. Shah AK, Fuerst D, Sood S, et al. Seizures lead to elevation of intracranial pressure in children undergoing invasive EEG monitoring. Epilepsia 2007; 48: 1097-103.
38. Claassen J, Mayer SA. Continuous electroencephalographic monitoring in neurocritical car. Curr Neurol Neurosci Rep 2002; 2: 534-40.
39. Jordan KG. Continuous EEG and evoked potential monitoring in the neuroscience intensive care unit. J Clin Neurophysiol 1993; 10: 445-75.
40. Jordan KG. Nonconvulsive status epilepticus in acute brain injury. J Clin Neurophysiol 1999; 16: 332-40.
41. Jordan KG. Continuous EEG monitoring in the neuroscience intensive care unit and emergency department. J Clin Neurophysiol 1999; 16: 14-39.
42. Scheuer ML. Continuous EEG monitoring in the intensive care unit. Epilepsia 2002; 43(Suppl. 3): 114-27.
43. Vespa PM, Nuwer MR, Nenov V, et al. Increased incidence and impact of nonconvulsive and convulsive seizures after traumatic brain injury as detected by continuous electroencephalographic monitoring. J Neurosurg 1999; 91: 750-60.
44. Tonnesen K, Balling H. Cerebral flow and metabolism in experimental liver failure. A comparison between hepatectomy and total hepatic devascularization in pigs. Acta Chir Scand 1986; 152: 439-45.
45. Davenport A, Bramley PN. Cerebral function analyzing monitor and visual evoked potentials as a noninvasive method of detecting cerebral dysfunction in patients with acute hepatic and renal failure treated with intermittent machine hemofiltration. Ren Fail 1993; 15: 515-22.
46. Sawhney IM, Verma PK, Dhiman RK, et al. Visual and auditory evoked responses in acute severe hepatitis. J Gastroenterol Hepatol 1997; 12: 554-9.
47. Jalan R, Sw OD, Deutz NE, Lee A, Hayes PC. Moderate hypothermia for uncontrolled intracranial hypertension in acute liver failure. Lancet 1999; 354: 1164-8.
48. Banoub M, Tetzlaff JE, Schubert A. Pharmacologic and physiologic influences affecting sensory evoked potentials: Implications for perioperative monitoring. Anesthesiology 2003; 99: 716-37.
49. Pfurtscheller G, Schwarz G, Schroettner O, et al. Continuous and simultaneous monitoring of EEG spectra and brainstem auditory and somatosensory evoked potentials in the intensive care unit and the operating room. J Clin Neurophysiol 1987; 4: 389-96.
50. Fossi S, Amantini A, Grippo A, et al. Continuous EEG-SEP monitoring of severely brain injured patients in NICU: Methods and feasibility. Neurophysiol Clin 2006; 36: 195-205.
51. Rubik J, Pietraszek-Jezierska E, Kaminski A, et al. Successful treatment of a child with fulminant liver failure and coma caused by Amanita phalloides intoxication with albumin dialysis without liver transplantation. Pediatr Transpl 2004; 8: 295-300.
52. Yang SS, Chu NS, Wu CH. Disappearance of N20 and P25 components of somatosensory evoked potential: An ominous sign in severe acute hepatitis. J Formos Med Assoc 1993; 92: 46-9.
53. Yang SS, Chu NH, Wu CH. Subcortical somatosensory evoked potentials in patients with hepatic encephalopathy caused by severe acute hepatitis. J Gastroenterol Hepatol 1993; 8: 545-9.
54. Goff WR, Shaywitz BA, Goff GD, et al. Somatic evoked potential evaluation of cerebral status in Reye syndrome. Electroencephalogr Clin Neurophysiol 1983; 55: 388-98.
55. Zandbergen EG, De Haan RJ, Stoutenbeek CP, Koelman JH, Hijdra A. Systematic review of early prediction of poor outcome in anoxic-ischaemic coma. Lancet 1998; 352: 1808-12.
56. Guerit JM. Evoked potentials in severe brain injury. Prog Brain Res 2005; 150: 415-26.